Basilea Pharmaceutica Company
Basilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland, and listed on the SIX Swiss Exchange (SIX: BSLN). Through the integrated research, development and commercial operations of its Swiss subsidiary Basilea Pharmaceutica International Ltd., the company focuses on providing innovative pharmaceutical products in the therapeutic areas of bacterial infections, fungal infections and oncology, targeting the medical challenge of rising resistance and nonresponse to current treatment options.
.png)
Employee Number:
101-250
Headquarters:
Basel, Basel-Stadt, Switzerland, Europe
Founded Date:
2000-01-01
Industry:
Drug Discovery & Development
Super Industry:
Biopharma & Life Science Tools
Phone Number:
41616061112
Investors:
Athyrium Capital Management LP, Biomedical Advanced Research and Development Authority (BARDA), CARB-X, U.S. Department of Health & Human Services
Ipo Status:
public
Stock Symbol:
BSLN
City:
Basel
Region:
Basel-Stadt
Country:
Switzerland